Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01899443
Other study ID # ISOAJRS_AU
Secondary ID
Status Completed
Phase N/A
First received July 10, 2013
Last updated March 21, 2017
Start date August 2013
Est. completion date December 2016

Study information

Verified date March 2017
Source South West Sydney Local Health District
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Primary total knee or total hip replacement surgeries are costly high volume procedures & outcomes may be affected by surgical & care processes & individual patient characteristics. The primary hypotheses is that non compliance with recommended practice impacts patient outcomes (e.g. the likelihood of complications following surgery). The primary aims of the study are to evaluate the links between processes & outcomes & if possible develop a model that will improve patient outcomes & reduce unnecessary practice variation whilst considering costs.


Description:

The primary aim of the study is to identify whether compliance with specific processes is associated with better outcomes.

The study is a longitudinal cohort study to examine outcomes after total hip and knee replacement surgeries. We hypothesise the site and patient level compliance is related to the prevalence of a subsequent complication (composite outcome comprising 30 day mortality, readmission, reoperation or surgical complication).

METHODS This study will select high volume (>275 cases annually) public and private hospitals across Australia. By involving public and private sites across Australia, the generalisability of the findings is enhanced. Each site will identify a site coordinator to oversee and manage the project at that site. Site coordinators are identified by each site. After hospital discharge, patients are followed up by the investigators.

This is a prospective observational study with projected sample of c.2200 consenting patients from up to 20 high volume hospitals. The site coordinator will screen, approach and consent eligible patients during routine preadmission processes. At the time of consent, the patient will be required to: provide socio-demographic details about themselves, past medical history, complete 2 standard patient reported outcome measures. Contact with patients about the study will be made by the site coordinator and routine hospital staff involved in their acute care. Acute data collection will involve prospective audit of medical records to collect peri- and post- operative acute care process data, client characteristics and outcomes by staff at each site. Random and convenience sampling will be used to identify eligible hospital sites which will remain anonymous.

Patient follow up regarding longer term outcomes will be completed via telephone by study investigators at three additional time points (approximately 35 and 90 days and 1 year post surgery) to collect repeat data as provided by each patient at the time of consent.

Descriptive statistics will be used to profile site level and patient level compliance with key processes of care. Multivariable logistic regression (MLoR) will be used to identify the association between the binary composite outcome measure and patient level compliance. Site and individual patient compliance with evidence based guidelines (where available) or best practice recommendations on key processes and relevant outcomes will be examined (e.g. Venous thromboembolism (VTE) prevention). Sample size calculations have been completed to ensure the analyses have sufficient power. If a useful association between processes and outcomes is identified, cost analyses with specific foci will be undertaken to consider costs for different factors and stages (e.g. acute / post discharge). Secondary analysis will determine the predictors of patient -reported outcomes. Depending on the results of initial data analyses, additional secondary analyses will potentially include analyses at additional time points (beyond initial 35 days) for association between key processes and outcomes, and analysis looking at the association between specific complications and compliance with specific processes.

Interim analysis will be undertaken to assess the level of observed compliance with key processes.

Re-abstraction of acute care data will be undertaken to ensure accuracy and completeness of submitted date from the sites.

Site survey Prior to study commencement at each site, the site coordinators will complete a survey detailing each surgeons protocols for key processes including their VTE and antimicrobial prophylaxes. The extent surgeon protocols align with Australian practice guidelines will be ascertained.

Additional secondary analyses will include, but may not be limited to:

1. a comparison of outcomes between patients who go to inpatient rehabilitation and those who go directly home after surgery. Propensity based scoring and matching will be used to determine if outcomes are better in one of the two groups

2. determination of the predictors of the 'unhappy knee' 12 months post surgery. A case controlled matched design will be used.

3. comparison in satisfaction with the acute care experience between private and public patients in a subset

4. a comparison of outcomes between THR patients with an anterior surgical approach and a posterior approach

5. description of ambulation profiles immediately post surgery and variables associated with early ambulation

6. snapshot of rehabilitation received after TKA or THA


Recruitment information / eligibility

Status Completed
Enrollment 1900
Est. completion date December 2016
Est. primary completion date December 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Primary elective unilateral or bilateral total knee arthroplasty (TKA) or total hip arthroplasty (THA)

- Primary diagnosis of osteoarthritis

- Aged 18 or over, either gender

- Able to comprehend the protocol and provide consent (e.g. be able to read English, have no history of dementia)

- Available for telephone follow-up within the first 6 weeks, 3 months and then at 12 months post surgery

- No further joint replacement surgery planned within the next 3 months of the current surgery

Exclusion Criteria:

- Cognitive impairment / history of dementia

- Hip replacement for fracture

- Revision of previous joint replacement

- Under 18 years of age

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Observation
This is an observational study observing relationship between routine care and outcomes after total hip or knee arthroplasty.

Locations

Country Name City State
Australia Concealed site 9 Private Melbourne Victoria
Australia Concealed site 15 Public Rural Queensland
Australia Concealed site 4 Public Rural New South Wales
Australia Concealed site 6 Private Rural New South Wales
Australia Concealed site 8 Private Rural New South Wales
Australia Concealed site 16 Public Semi Rural New South Wales
Australia Concealed site 1 Public Sydney New South Wales
Australia Concealed site 17 Private Sydney New South Wales
Australia Concealed site 2 Public Sydney New South Wales
Australia Concealed Site 3 Public Sydney New South Wales
Australia Concealed site 5 Private Sydney New South Wales
Australia Concealed site 10 Public Urban Victoria
Australia Concealed site 11 Private Urban Tasmania
Australia Concealed site 12 Private Urban South Australia
Australia Concealed site 13 Private Urban Queensland
Australia Concealed site 14 Public Urban Queensland
Australia Concealed site 18 - 2 Public sites Urban Victoria
Australia Concealed site 7 Private Urban New South Wales

Sponsors (1)

Lead Sponsor Collaborator
South West Sydney Local Health District

Country where clinical trial is conducted

Australia, 

Outcome

Type Measure Description Time frame Safety issue
Other Day of first ambulation attempt post surgery The first post-operative day the patient walked, including any partial or full weight-bearing activities such as walking on the spot, bed-to-chair and bed-to-toilet).
first post-operative day that patients walked, including any partial or full weight-bearing activities 134
such as walking on the spot, bed-to-chair and bed-to-toilet).
day 0-14 post-surgery
Primary Percentage of participants experiencing the composite outcome up to 35 days post surgery. The proportion of patients in each group (compliant and non-compliant groups) that experience one or more of the following outcomes - death, readmission, reoperation or surgical complication - up to 35 days post-surgery. Analyses will adjust for patient and service provider confounders. 35 days post total hip or knee replacement surgery
Secondary Patient-reported quality of life The EuroQual 5-level (EQ5D) assessment will be used to capture patient-reported quality of life. 35 days post surgery
Secondary Incidence of venous thromboembolism The number of patients treated with a documented blood clot 90 days post surgery
Secondary Incidence of deep infection. The number of patients with a documented deep infection. That is, were treated with intravenous antibiotics for their index joint, was readmitted to hospital, and/or had a joint washout. 365 days post surgery
Secondary Costs of care processes The cost of individual care processes, the cost of healthcare utilisation post discharge from acute care, carer costs and cost of time off work will be calculated for each person. Data will be collected using patient diaries and derived from the acute care study data. 90 days post surgery
Secondary Patient reported quality of life (QoL) The EQ5D will be used to capture patient-reported QoL 90 days post surgery
Secondary Health-related QoL The EQ5D will be used to capture QoL 365 days post surgery
Secondary Patient reported joint pain and function The Oxford Knee or Hip Score will be used to capture patient reported joint specific pain and function. 90 days post surgery
Secondary Patient reported joint pain and function The Oxford Knee or Hip Score will be used to capture patient reported joint specific pain and function 365 days post surgery
See also
  Status Clinical Trial Phase
Completed NCT04657926 - A Trial of APPA in the Treatment of Knee Osteoarthritis Phase 2
Completed NCT02536833 - A Study Evaluating the Safety, Tolerability, and Efficacy of SM04690 Injected in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis Subjects Phase 2
Completed NCT03014037 - Comparing Mesenchymal Stem Cell Counts in Unilateral vs. Bilateral Posterior Superior Iliac Spine Bone Marrow Aspiration N/A
Recruiting NCT05937542 - A Qualitative Investigation of CLEAT Participants
Completed NCT03644615 - A Mindfulness Program (MBSR) in the Management of Symptomatic Hip and Knee Osteoarthritis N/A
Recruiting NCT06061367 - Muscles Strength and Gait Parameteres After TKA
Withdrawn NCT04976972 - A Comparison of Patients Receiving a Total Knee Replacement With Robotic Assistance or With Conventional Instrumentation N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT03850665 - Comparison of Functional Outcome in Patients After Hip Arthroplasty Depending on Surgical Approach N/A
Completed NCT02826902 - Effect of Anesthesia on Quality of Recovery in Patients Undergoing Correctional Tibial Osteotomy - A Randomized Controlled Trial N/A
Completed NCT04402502 - Dynamic 4DCT to Examine Wrist Carpal Mechanics N/A
Completed NCT02923700 - Leukocyte-rich PRP vs Leukocyte-poor PRP for the Treatment of Knee Cartilage Degeneration: a Randomized Controlled Trial Phase 4
Completed NCT04564053 - Study of Safety, Tolerability and Pharmacokinetics of LNA043 in Japanese Osteoarthritis Participants Phase 1
Completed NCT05070871 - A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women N/A
Not yet recruiting NCT05036174 - Diphenhydramine Ointment for Knee Osteoarthritis N/A
Recruiting NCT02666443 - Low Dose Dexamethasone in Supraclavicular Blocks N/A
Recruiting NCT02912429 - Onlay vs. Inlay Patellofemoral Arthroplasty N/A
Active, not recruiting NCT02723929 - Effects of tDCS and tUS on Pain Perception in OA of the Knee
Withdrawn NCT02921594 - Kinematic Comparison of Vanguard XP and Vanguard CR Total Knee Arthroplasties N/A
Terminated NCT02820766 - Journey II BCS CMS Total Knee System Compared to Other PS Total Knee Systems in PT Setting N/A